TY - JOUR ID - 154681 TI - Antibacterial Activity of Modified Carvacrol against Staphylococcus epidermidis and Pseudomonas aeruginosa JO - Journal of Preventive and Complementary Medicine JA - NCM LA - en SN - AU - Ghod Elahi, Mona AU - Hekmati, Malak AU - Esmaeili, Davoud AU - Ziarati, Parisa AU - Yousefi, Mohamad AD - Department of Organic Chemistry, Faculty of Pharmaceutical Chemistry, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran AD - Department of Microbiology and Applied Virology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran AD - Department of Medicinal Chemistry, Pharmacy Faculty, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran AD - Department of Chemistry, Faculty of Pharmaceutical Chemistry, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran Y1 - 2022 PY - 2022 VL - 1 IS - 4 SP - 192 EP - 196 KW - antibacterial KW - Modified carvacrol KW - Staphylococcus epidermidis KW - Pseudomonas aeruginosa DO - 10.22034/ncm.2022.350997.1051 N2 - Background: Carvacrol, a prominent phenolic compound found in Satureja and thyme, possesses a wide range of beneficial properties, including antibacterial, antifungal, anti-inflammatory, and anti-cancer activities. Objectives: This study aimed to determine the antibacterial effects of peptide-modified carvacrol on Staphylococcus epidermidis and Pseudomonas aeruginosa. Methods: Using disk diffusion and MIC methods, the antibacterial activity of peptide-modified carvacrol against Staphylococcus epidermidis and Pseudomonas aeruginosa was evaluated. Results: The modified carvacrol demonstrated growth inhibition diameters of 25mm and 20mm against Staphylococcus epidermidis and Pseudomonas aeruginosa using the disk diffusion method. The minimum inhibitory concentration (MIC) against Staphylococcus epidermidis and Pseudomonas aeruginosa was 1 g/ml and 0.51 g/ml, respectively. Conclusion: Peptide-modified carvacrol displays antibacterial effects. UR - https://www.nclinmed.com/article_154681.html L1 - https://www.nclinmed.com/article_154681_34d20ed55a582ad41888bbc23b46599e.pdf ER -